2. UroToday Home
  3. Video Lectures

Precision Medicine: PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Videos

Copper-67 (Cu-67 or 67Cu) in Cancer Therapy: Current Developments and Future Potential - Alan Taylor
July 31, 2024
Details
COBRA Trial: Evaluating 64Cu-SAR-bisPSMA PET Imaging for Prostate Cancer Detection - Phillip Koo
June 10, 2024
Details
Highlights: UCLA/UCSF Inaugural PSMA PET and RLT Conference - Jeremie Calais
January 30, 2024
Details
Nuclear Medicine Physician Discusses Career Path and Field Growth - Louise Emmett
November 20, 2023
Details
ENZA-p Trial Shows Promise for Enzalutamide-Lutetium Combination in Prostate Cancer - Louise Emmett
November 20, 2023
Details
The Evolution of PSMA Theranostics: A 30-Year Journey with the Prostate Cancer Foundation - Andrea Miyahira
November 2, 2023
Details
A Historical Perspective on Radioligand Therapy and Novel Treatment Modalities in the Management of mCRPC - Neil H. Bander
February 6, 2023
Details
PSMA PET Imaging Hot Topics - Neal Shore & Jason Efstathiou
November 4, 2022
Details
Imaging and PET Analysis as a Prognostic Tool for Lu-PSMA-617 Treatment in Patients with mCRPC - Phillip H. Kuo
October 16, 2022
Details
Clinical Trial Equity in Radionuclide Treatment for Prostate Cancer - Joseph Osborne
April 7, 2022
Details
Clinical Implementation of Pluvicto™ (177Lu-PSMA-617) - Michael Morris
April 3, 2022
Details
Pluvicto™ (177Lu-PSMA-617) Indications for Clinical Use in PSMA Positive Metastatic Castration-Resistant Prostate Cancer mCRPC - Oliver Sartor
March 28, 2022
Details
Pluvicto The First Targeted Radioligand Therapy for Treatment of Metastatic Castration-Resistant Prostate Cancer FDA Approved - Charles Ryan and Alicia Morgans
March 23, 2022
Details
Radiopharmaceuticals in Prostate Cancer: A Deep Dive into Patient-Reported Outcomes - Scott Tagawa
September 15, 2021
Details
The Upfront PSMA Study: Shifting Paradigms in Metastatic Hormone-Sensitive Disease - Declan Murphy & Arun Azad
July 1, 2021
Details
Lutetium-177 PSMA: A Closer Look at Its Therapeutic Potential and Side Effects - Bennett Chin
May 14, 2021
Details
Radionuclide Targeted Treatment in Progressing Metastatic Prostate Cancer - Michael Hofman
June 30, 2020
Details
PSMA-PET Imaging in Prostate Cancer & PSMA as a Therapeutic Target in Prostate Cancers - Thomas Hope and Johannas Czernin
June 30, 2020
Details
PSMA-directed Therapy - Scott Tagawa and Michael Morris
June 30, 2020
Details
PSMA Targeted Radiopharmaceuticals in Prostate Cancer: Pivotal Phase III VISION Trial - Oliver Sartor
June 30, 2020
Details
Precision Medicine: RadioIsotopes Targeted Therapies in Cancer - Stefano Fanti
June 30, 2020
Details
Academic and Community Practice Perspectives on Integrating PSMA Lutetium in the Clinic: Lessons Learned from Radium-223 Experience - Oliver Sartor and Nicholas Vogelzang
June 30, 2020
Details
Radiation Safety with Targeted Radionuclide Therapy - Thomas Hope
June 30, 2020
Details